chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash on right side of neck presumed by physician to be shingles. Rash appeared 8 days after second Pfizer vaccine and symptoms were examined by internists and consistent with shingles symptoms.  Rash has begun to dry up and begin to improve. Had chicken pox at age 10 and am too young to have received the shingles vaccine.
By 11/22/13 patient began to experience ascending dysesthesias and eventual weakness.  MRI of brain and Spine revealed demyelination in the cervical spine and brain with evidence for active enhancing lesions.
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. A female patient of an unspecified age received TRUMENBA via an unspecified route of administration on an unspecified date at single dose for immunisation. Relevant medical history and concomitant medications were not reported. On an unspecified date, the patient experienced rash. The rash was on her arm or arms; it was unknown if it was one or two arms but that's where the rash was. At the time of the report, the outcome of the event was unknown. The information on the batch number has been requested.
Moderna COVID-19 Vaccine EUA Fever, chills, Head ache, Nausea
Approximately 24 hours post vax the pt developed a fine red rash on both forearms from the elbows to the wrists, very itchy.  Pt was seen by physician and treated with Prednisone and Benadryl for 5 days. The rash subsided in about one week with no recurrence.
Pt had swelling from shoulder to right elbow that started on 6/6/00 with slight redness noted and very warm to touch. Took to ER and was given Benadryl. On 6/7/00, swelling was down and he is moving arm well.
Pt called health system call center reporting she felt dizzy and weakness. Reported some left sided numbness on her left leg. She had received her pfizer vaccine on 5/3/21 outside of the county from her workplace (but no other information provided). Pt was advised to for to ED as soon as possible
4 days after receiving the vaccine on 1/31, she experienced burning in her legs and feet; a few days later she had some SOB with activity (walking up stairs), lethargy and  "tired" feeling in her arms and legs - all of these symptoms persist
Patient was admitted to the hospital, critically ill and intubated in the ICU with encephalomyelitis consistent with acute disseminated encephalomyelitis (ADEM) associated with MOG-IgG positivity (or MOGAD).  Course complicated by respiratory failure, paroxysmal sympathetic hyperactivity,  optic neuritis, staph aureus tracheitis requiring antibiotics and ongoing encephalopathy. - underwent thorough infectious work up, multiple MRIs, lumbar puncture and brain biopsy - underwent several days of electroencephalogram (EEG) - Received 5 days IV methyl prednisone followed by a slow taper - Received 6 days of plasma exchange or PLEX - Received IVIg 2mg/kg (and will received monthly IVIg for 6 months)
24 y old female suffered from syncope 10 min after vaccination. Pt lost consciousness for 20 sec. Pt was held up by boyfriend and did not fall to the ground.  Patient was put in supine position on the ground, regained consciousness immediately after lying down. Pt stayed in this position for 10 min and was then assisted to a chair where she remained for another 10 min. She was given water and a candy. Pt stated she felt fine and that she was ready to go. Paramedics arrived but, pt  was not transported to a hospital as per her request.  BP 110/75, P 66, RR 16
This spontaneous report as received from an office staff member who is also the vaccine coordinator and the administrator of the vaccine for the patients, who reported that on an unspecified date in 2013 (within the last 30 days), an adverse reaction occurred for 2 males patients and 2 female patients (ages ranged from 18 months old to 21 years old), that received a doses of VARIVAX (Merck) subcutaneously, "standard dose" (exact doses not reported), for prevention of VARICELLA. Each of the 4 patients were given the VARIVAX (Merck) from one of two lots: lot # H017243 (Exp: 17-SEP-2014) and lot # H018791 (Exp: 15-OCT-2014). Also it has been reported that one of the patient received the VARIVAX (Merck) with MMR II (dose, route and lot # not reported) at separate injection sites; one patient received the VARIVAX (Merck) with MMR II (dose, route and lot # not reported), and diphtheria toxoid, pertussis vaccine (unspecified), tetanus toxoid vaccine (injection sites unspecified); one patient received the VARIVAX (Merck) with INFANRIX (injection sites unspecified); one patient received the VARIVAX (Merck) with GARDASIL (dose, route, site and lot # not reported). The reporter stated that within 2-3 days of injection, all of these patients developed red, hot, itchy, sore, areas around their injection site after receiving the vaccine. "Some" of the patients also developed blistering areas that were raised and one of the patients had also developed a 101 degree fever. Two above mentioned lots of VARIVAX (Merck) have been pulled from use at the office. These were all "VFC doses". The physician was also told to pull the diluents used for administration, however the diluents had already been depleted. All patients were given BENADRYL and 2 also received an unspecified antibiotic. At the time of the report the outcome of the events was unknown. The patients sought medical attention - they talked with doctor. Additional information has been requested.
Pt recvd Hep B vax MAY92 w/no adverse reaction; in JUN pt was vaxed w/the 2nd dose devel a burning sensation upon injection as well as soreness & or an aching sensation in arm; heaviness in the arm;
3 other siblings with + varicella, without vaccination, only child in family with vaccine. Low grade fever, more than 100 lesions over body.  Follow up on 12/01/03: "4 sibs with chickenpox, only one who received varivax."
Chronic sinusitis; This is a spontaneous report from a contactable healthcare professional, the patient. A 22-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8731) via unspecified route of administration in left arm on 17Apr2021 at 10:15 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included SINGULAIR, PROZAC, SYNTHROID and lisinopril (MANUFACTURER UNKNOWN) taken within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) as a single dose via unspecified route in left arm on 21Mar2021 at 12:15 for COVID-19 immunisation. Past drug history included penicillin and peanut. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Apr2021, at 13:00, the patient experienced chronic sinusitis. The patient reported that she could not breathe out of nose at all, constant post nasal drip and dried out nasal passages. Corrective treatment included Afrin nasal spray and other nasal sprays for an unspecified date. The clinical outcome of chronic sinusitis was not resolved.   No follow-up attempts are needed. No further information is expected.
5/25/2021   I was having intense and frequent heart palpitations. I went to Dr. who referred me to a Heart Specialist, Dr.  I had an EKG, Stress test and an MRI with the dye. I was prescribed Flecainide. MRI showed my heart was functioning normally, that is was electro physiological. My stress test showed my  heart was not exacerbated by exercise , but by food like caffeine or sugar. EKG revealed you had PVC's.  My heart function is good, but the PVC's could cause heart damage.  I have been on various medications, but this is the one I have been on the longest that is helping. Dr. told me since I have no preexisting issues, she has been seeing  this same result in other people who have had the vaccine.  I still have not recovered.
"KNOT" ON THE INJECTION SITE; ERYTHEMA ON INJECTION SITE; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 60 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 10808987 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 15:59 at right deltoid for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the subject experienced "knot" on the injection site. On 30-MAR-2021, the subject experienced erythema on injection site. On 30-MAR-2021, the subject experienced injection site pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from erythema on injection site on 03-APR-2021, and had not recovered from "knot" on the injection site, and injection site pain. This report was non-serious.
arm soreness; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) and PYREXIA (fever) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ) for Blood pressure management.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced PAIN IN EXTREMITY (arm soreness) and PYREXIA (fever). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm soreness) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-215288 (Patient Link).
patient was 7 weeks pregnant and miscarried 2 days after having gotten her vaccine. this was her first pregnancy.
at 2:30 am I woke up suddenly and violently vomited about 5 times, followed by cold chills and a weakness that I have never experienced before. Then had explosive diarrhea for another 5 to 6 hours.  Temperature was 96, usually 96.7 so no fever, but I was sweating and shivering. I drank water and sipped soda, slept all day and all night and woke up the following day as if nothing had happened. My arm never hurt and was not red.  This bad reaction was from 2:30am until 8:30am, the rest seemed to be normal or expected.
Bleeding right after the first shot; Pregnant; A spontaneous report  was received from consumer, concerning herself, a 39-year-old, pregnant female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a bleeding right after the 1st shot, pregnant.  The patient's medical history include 3 miscarriages on Dec 2013 , Feb 2013, Apr 2013 (all not more 2months). Products known to have been used by the patient, included Progesterone 300mg indicated for after 3miscarriages, Tylenol, Folic acid 1mg .  On 18JAN 2021, prior to onset of events, the patient received their first of two planned doses  of mRNA-1273 (Lot number: 041L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 22 FEB 2021, prior to onset of events, the patient received their second of two planned doses of mRNA-1273 (Lot number: 022M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 18 Jan 2021, the pregnant patient was exposed to the mRNA-1273 vaccine. She experienced bleeding right after the 1ST shot. She would like to be enrolled into the pregnancy registry. On 15JAN2021, the patient received a positive pregnancy test. Her last menstrual period was on 07 DEC 2020 and conception date was unknown. The patient's estimated due date is 12SEP2021.  No treatment information was provided.  Relevant laboratory test on 22 Feb 2021 last Ultrasound were done and the Result were normal.   Action taken with mRNA-1273 in response to events were not provided.  The outcome of the event bleeding right after the 1st shot was unknown and pregnant is ongoing.; Reporter's Comments: This is a case of product exposure on a 39-year-old pregnant of unknown gestation (LMP 07 DEC 2020)  and experienced PV bleed right after the first shot.  Very limited information regarding this event has been provided at this time. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
This spontaneous report was received from a registered nurse refers to a patient of 9 month old. On 19-JUL-2013, the patient was vaccinated with a dose of 0.5 ml (milliliter) VAQTA (lot # H019104, expiry date 19-JUL-2015, route intramuscular). The patient received a dose of VAQTA before the patient was 12 months old and no adverse effect was reported. Additional information has been requested.
Severe headaches behind R eye which started on 5/17/21 (pain alleviated with 600mg ibuprofen or with Excedrin), high blood pressure (143/93), heart palpitations. Headaches lasted 16 days until 6/1/21. Saw doctor on 6/2/21 but headaches never returned. All lab results and medical tests came back within normal limits.
Significant loss in breast milk. From regular pumping of 6oz to merely 2oz. Heavy menstrual twice in one month following vaccine. 1st menstrual 11/11/2021-11/22/2021 (heavy). 2nd menstrual 12/4/2021- 12/10/2021 (regular).
feeling cold throughout the day; sore area on her arm; This is a spontaneous report from a contactable nurse (patient). A 76-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL8982 and expiration date was not reported) intramuscularly on 02Feb2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was scheduled to receive the second dose on 23Feb2021. It was stated that she had heard rumors by word of mouth and blogs that the second shot is a real doozer. Some of the things she had heard were really disturbing and was hearing that a lot of elderly people had died from the second shot. On an unspecified date, patient was having a sore area on her arm and feeling cold throughout the day after receiving the first injection, and state that both of those side effects passed throughout the day. Patient asked how many people had died after receiving the second vaccine and probably doesn't have right up to the minute information about how many people were dying from this vaccine. Patient reported that she had friends that took the second dose and they all had chills, body aches, headache and fevers. Patient also asked If she don't take the second shot, or take it months later from now, and a new variant strain comes out, will she more susceptible to the new variant strain by not taking the second shot and being covered totally and stated Dr. (Name)came out and said if she don't take the second dose, she will be more susceptible to the variant strain attacking her and she could die from it. Patient wanted to know instead of taking her second vaccine next week, can she delay it and take it months from now and asked will the vaccine be effective. Patient wondered why there was no expiration date on her vaccine record card. She made the comment might be because it was so new, that's why there wasn't one. The outcome of the events was unknown.
This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient. A 27-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 27 years, in left arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunization. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient did not receive other medication in 2 weeks. Patient had no known allergies. Reported that 6 days after finishing treatment, she became very congested again and had nasal discharge. Patient received Paxlovid (anti viral treatment) from 01Jul2022 to 06Jul2022 for COVID-19 treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events and the suspect drug BNT162B2.
I started to feel chills and I had cold symptoms. One of my co-workers tested positive. I went to the Urgent Care and I tested positive for COVID-19. I was very achy and I had no energy. I was not able to do very much and I slept all day. I am still having trouble with catching my breath after three months. I only had a low-grade fever. I lost my sense of taste and smell for over two weeks. I could taste before I got my sense of smell back and it is still not a normal sense of smell for me. I just used Nyquil to control the aches and so that I could sleep.
Other serious/important medical incident: Mental anxiety, depression A week after taking my first shot, I experienced a feeling of anxiety, nervousness, could not sleep and depression! This was after the Pfizer shot
High heart rate; hypertension; This is a spontaneous report from a contactable pharmacist.  A 49-years-old female no pregnant female patient received ,at hospital, the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) from lot# EL3249 on 12Jan2021 at SINGLE DOSE for covid-19 immunisation .  Medical history included diabetes mellitus, ongoing hypertension,  high cholesterol.  Concomitant medication included metformin (METFORMIN), atorvastatin (ATORVASTATIN), hydrochlorothiazide, losartan potassium (LOSARTAN HCTZ).  On 13Jan2021 the patient experienced high heart rate and .Lab data included heart rate (13Jan2021): high   Outcome of the events was recovering. No Covid prior vaccination, No covid tested post vaccination
Severe chills and nausea. Chills are gone but still haven't eaten in 3 days.
Severe Pain at injection site started immediately following vaccination on March 27, 2021. Three days later, I experienced a severe headaches (which has discontinued). However, muscle aches, shortness of breath, leg pain is on-going.
The following day localized arm pain at injection site. For 3 days after I felt like I had Covid again. Severe body aches, fevers, weak. Since then I've been having severe headaches, nausea, extremely weak, body aches, taking Tylenol every 4 hours. Went to the ER and tests were fine though and Covid test negative. 1.5 day after the vaccine it triggered my menstruation the worst in my life 2.5 weeks early. I had blood work a week later and my hemoglobin is fine but my ferritin level was 9. I am now undergoing iron infusions for 4 weeks now. I am very regular for 13 years so the vaccine DEFINITELY brought it on. 2 weeks later I'm a still having headaches. Can barely stay awake in the afternoon, brain fog, and still body aches. I just feel horrible. It's affected my work.
2-inch diameter red mark at the injection site, the outer part is darker; Has lumps under the skin; When you press, it hurts; Itches; A spontaneous report was received from a Reporter concerning a 30 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273)  The patient's medical history was not provided. No relevant concomitant medications were reported.  Patient who is a pharmacy technician received the 1st Moderna vaccine 12Jan2021 2pm on left upper arm. The next day she noticed a red mark on the injection site. She states it has been getting bigger. On her arm she has a 2-inch diameter red mark at the injection site. The outer part is darker and has lumps under the skin and when you press it hurts and itches. No treatment taken. Wants to know if this is normal. Allergies include penicillin and seasonal. PMH includes Hashimoto's thyroiditis. No further information provided. Caller consents to follow up with her and HCP No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.
Fetal Demise. Patient presented on 10/29/09 10:30 PM with decreased fetal movement since 10/28 AM and was diagnosed with intrauterine fetal demise.  Work-up to date significant for +K-B indicative of likely fetal-maternal hemorrhage as the cause. 11/5/2009 MR and DC records for 10/30-31/2009. Patient presented with c/o's no fetal movement for past day, 38 wks, EDD 11/12/2009. US verified no fetal movement. no fetal heartbeat.  Pregancy complicated with a choroid plexus and marginal cord insertion. Tx: Induced labor :Misoprostol IV then Pitocin. Fetal autopsy requested. DC Dx: stillbirth
rash on both arms says it look's like circles with blood in them from her hands to her elbow
Patient received second dose of shingles shot 1/13/2022 at physical.  Side effects reported by patient: Headache, joint pains, nausea, sore arm.  Patient reported arm extremely sore to the point where can barely lift it, and also lymph nodes in left arm (shot site) is all swollen, to be about the size of a golf ball.  Its very tender to touch., underarm is very uncomfortable.  Patient reported taking  Tylenol 2 tabs for pain.
I was vaccinated 2 times, per protocol for shingles with SHINGRIX. Both times I became bedridden with aches, headache and mild nausea. Injection site swelling and pain and under arm swelling and pain of the same arm (Left). I received an injection for shingles and was told it was 2 shots within 6 months to complete the protection against shingles. The shots were given May 9, 2018 and Oct 24, 2018. The day after each shot, I became very ill. Chills, aches, bad headache, mild nausea. My arm hurt bad and was swollen at the injection site and under my arm (sore arm - left). I called to ask if this was normal and was told it's a very good shot and gives 90% protection against shingles and some people have those reactions and it was normal for this vaccine. I don't think that is a normal reaction and I wanted to report it.
On 9-29-2018 patient contacted reporter to report adverse reaction to the the SHINGRIX vaccination given on 9-26-2018. Patient stated later on that same day she received the vaccine both arms became increasingly weak. Patient stated the 'weakness'  became increasingly more pronounced throughout the day. Patient stated at the time of her reporting the adverse reaction to reporter both arms are still feeling 'weak' but the condition has greatly improved. Reporter stated to patient she should seek medical attention and she stated she plans on making an appointment with her md.